| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |